Health Care & Life Sciences » Biotechnology | Bionor Pharma ASA

Bionor Pharma ASA

Bionor Pharma ASA ADR
Stock Exchange Other OTC
EPS
 -
Market Cap
 -
Shares Outstanding
 1.4 M
Public Float
 -
Bionor Pharma ASA
Stock Exchange Other OTC
EPS
 $0.09
Market Cap
 $318.29 M
Shares Outstanding
 56.13 M
Public Float
 -
Bionor Pharma ASA
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 56.52 M
Public Float
 -

Profile

Address
Olav Vs gate 5
Oslo PS 0161
Norway
Employees -
Website http://www.soloneiendom.no
Updated 07/08/2019
Solon Eiendom ASA engages in investing and developing real properties with focus on housing projects in Oslo and Akershus. It operates through the Property Development and Other segments. The firm also has investments in other companies and businesses.

Financials

View All
Created with Highcharts 5.0.14Bionor Pharma ASANet Income. Fiscal year is January-December. All values NOK Thousands.85 43485 43468 05468 05496 72696 72623 54723 54769 73769 737136 624136 624201320142015201620172018025k50k75k100k125k150k
Created with Highcharts 5.0.14Bionor Pharma ASASales/Revenue. Fiscal year is January-December. All values NOK Thousands.4 2004 2001 7661 7668585691 497691 497883 036883 036924 053924 0532013201420152016201720180250k500k750k1 000k

Runar Vatne
Director
Sofia Katarina Finneng
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.